Remaining Resilient After 2020March 08, 2021 Ravi Samavedam
Utilizing Azzur Cleanrooms on Demand™️ to Accelerate Early-Phase Biopharmaceutical Manufacturing
Remaining Resilient After 2020
With immense growth projected for the pharmaceutical, biotechnology, and medical device areas in the next five years, now is the time to set yourself up for success.
From this Hanson Wade webinar hosted by Ravi Samavedam, Chief Innovation Officer (CINO) Azzur Group, you will be leaving with a full breadth of knowledge on…
- Industry growth trends and future demands
- Current industry challenges for early-phase manufacturing
- How Azzur Cleanrooms on Demand™️ can help cut your timeline by as much as 50%
This webinar is complete with informative case studies that showcase how a hybrid model can solve a host of early-phase manufacturing challenges.
In early-phase manufacturing you have a few options—one locks you into facility oversight and maintenance, the other makes you reliant on third-parties with no rights to your IP.
But what about a better solution?
Azzur Cleanrooms on Demand™️ has a third option for you: one that serves to accelerate your manufacturing, and provide you with the resources to succeed right from the beginning while keeping your proprietary IP yours.